跳至主要内容
临床试验/JPRN-UMIN000007727
JPRN-UMIN000007727尚未招募未知

A randomized clinical trial on the efficacy and tolerability of dose reduction and escalation regimen of Trimethoprim/Sulfamethoxazole (TMP/SMX) in patients with rheumatic diseases - A study on dose reduction and escalation regimen of TMP/SMX

Tokyo Medical and Dental University0 个研究点目标入组 165 人开始时间: 2012年4月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. When a patient refuses to give or withdraws his or her consent 2. When a patient has contraindications or contraindications in principle (see attachment 3) for TMP/SMX 3. When a patient uses biologics concomitantly 4. When a patient has a history of Pneumocystis pneumonia 5. When a patient has uncontrollable comorbidities (i.e., severe diabetes, unstable ischemic heart disease, stroke within the last 1 year) 6. When a patient's body weight is less than 40kg 7. When a patient is under breastfeeding or pregnant, or has a plan to be pregnant in 24 weeks

研究者

相似试验